This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Ghent. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: Annelies Deceuninck: Innovator in Peptide Cross-Linking
Introduction
Annelies Deceuninck is a prominent inventor based in Ghent, Belgium. She has made significant contributions to the field of peptide chemistry, particularly in the area of cross-linking peptides. With a total of 2 patents to her name, her work is paving the way for advancements in biochemistry and related fields.
Latest Patents
Annelies Deceuninck's latest patents focus on a method for cross-linking peptides using an activated furan-moiety. The invention outlines a detailed process that includes several steps: first, providing a composition of furan-peptides that contain at least one amino acid with a furan-moiety. Next, this composition is mixed with second peptides to create a mixture. An activation signal is then added to this mixture, activating the furan-peptides. Finally, the activated furan-peptides are reacted with the second peptides, resulting in cross-linked peptides. This innovative method has the potential to enhance the functionality of peptides in various applications.
Career Highlights
Annelies Deceuninck is affiliated with the University of Ghent, where she conducts her research and develops her inventions. Her academic background and research experience have positioned her as a leading figure in her field.
Collaborations
Annelies collaborates with notable colleagues, including Annemieke Madder and Kurt Hoogewijs. These partnerships enhance her research capabilities and contribute to the advancement of her innovative projects.
Conclusion
Annelies Deceuninck is a trailblazer in peptide chemistry, with her innovative methods for cross-linking peptides showcasing her expertise and creativity. Her contributions are significant in the scientific community and hold promise for future advancements in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
